<DOC>
	<DOCNO>NCT00281281</DOCNO>
	<brief_summary>1 . Vancomycin drug require precise dose close monitoring avoid drug toxicity . 2 . There limited data change vancomycin pharmacokinetics patient need extracorporeal membrane oxygenation ( ECMO ) . 3 . This control trial understand : 1. whether pharmacokinetics vancomycin influence use ECMO 2. design appropriate dose vancomycin adult patient use ECMO .</brief_summary>
	<brief_title>Pharmacokinetics Vancomycin Adults Receiving ECMO</brief_title>
	<detailed_description>1 . Vancomycin drug require precise dose close monitoring avoid drug toxicity . 2 . Oftentimes use intensive care unit ( ICU ) patient need life-saving machine heart lung failure call extracorporeal membrane oxygenation ( ECMO ) . 3 . There limited data change vancomycin pharmacokinetics patient . 4 . This control trial use ICU patient need vancomycin ECMO control understand : 1. whether pharmacokinetics vancomycin influence use ECMO 2. design appropriate dose vancomycin adult patient use ECMO . 5 . After 4th dose vancomycin , blood drawn appropriate time spot ( 1 mL ) determine time concentration curve calculate pharmacokinetic parameter 2 group patient determine difference .</detailed_description>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>&gt; 18 y/o receive ECMO study group without ECMO control group ( sex , age , creatinine clearance match study group ) severe burn ( &gt; 3040 % BSA ) receive continuous renal replacement therapy hemodialysis concurrently</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Extracorporeal Membrane Oxygenation</keyword>
	<keyword>vancomycin</keyword>
</DOC>